Hudson Bay Capital Management »

An2 Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $118k 35k 3.42

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
Almitas Capital
Vanguard Group
Vanguard Capital Management
Woodline Partners
Ameriprise Financial
Stonepine Capital Management
Ally Bridge Group
Bank of Nova Scotia
Bank of America Corporation
Renaissance Technologies
BlackRock
Jane Street

View all funds holding An2 Therapeutics